ArticleInternational journal of molecular sciences2021

Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model.

Savina Apolloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.